Refractory facial erythema in a young woman
A 26-year-old woman presents with a 2-year history of flushing and persistent erythema over the central face, with papules and pustules on the cheeks and chin but no comedones. She has tried topical metronidazole 0.75% gel and a 3-month course of oral doxycycline 100 mg daily with partial improvement. She reports that her face stings with most moisturisers and that her symptoms worsen with sun exposure and hot drinks. She has no ocular symptoms. She is using a 'gentle' cleanser and an over-the-counter anti-redness cream. On examination there is telangiectasia over both cheeks, background erythema, and 8–10 inflammatory papules. She asks about isotretinoin because a friend's acne cleared on it.
1. How do you confirm the diagnosis and differentiate rosacea from its mimics in this patient?
Read the worked answer
Diagnostic reasoning The constellation of flushing, persistent centrofacial erythema, telangiectasia, and inflammatory papules/pustules without comedones is classic for papulopustular rosacea (with an erythematotelangiectatic component). The absence of comedones is the key discriminator from acne vulgaris. The stinging with products suggests a compromised skin barrier, common in rosacea.
Mimics to consider
- Acne vulgaris - comedones present; usually younger onset; responds to retinoids/benzoyl peroxide.
- Seborrhoeic dermatitis - scale in nasolabial folds, eyebrows, and scalp; responds to antifungals.
- Systemic lupus erythematosus - malar rash is usually sparing of nasolabial folds, may scar, and is associated with systemic features; check ANA, anti-dsDNA, urinalysis, and CBC if any suspicion.
- Dermatomyositis - heliotrope, Gottron papules, proximal weakness; check CK and myositis antibodies if suspected.
- Demodicosis - can cause papulopustular eruption; consider skin scraping or standardised skin surface biopsy if refractory.
- Perioral dermatitis - history of topical steroid use, papules around mouth.
- Carcinoid syndrome / mastocytosis - flushing with systemic symptoms (diarrhoea, wheeze); consider 24-hour urinary 5-HIAA or serum tryptase if flushing is prominent.
- Topical steroid-induced rosacea - ask specifically about prior steroid use.
Confirmatory steps
- Detailed history: triggers, prior treatments including steroids, ocular and systemic symptoms.
- Examination of the whole face, scalp, and eyes; look for telangiectasia and phymatous change.
- Consider ANA and urinalysis to exclude lupus if the rash is atypical or there are systemic features.
- Consider Demodex assessment if refractory.
Classification Document the subtype(s) and severity (e.g., Investigator's Global Assessment) to guide therapy and track response.
2. Given her partial response to metronidazole and doxycycline, what is your stepwise treatment plan, and how do you address her request for isotretinoin?
Read the worked answer
Stepwise plan
- Optimise topical therapy. Metronidazole alone is often insufficient. Add ivermectin 1% cream once daily (effective for papulopustular rosacea, particularly with Demodex) or azelaic acid 15% gel twice daily. Consider brimonidine 0.33% gel or oxymetazoline 1% cream for persistent erythema and flushing (vasoconstrictors; rebound possible).
- Barrier repair and trigger avoidance. Recommend a fragrance-free, low-irritant moisturiser and mineral sunscreen (SPF 30+). Advise on avoiding hot drinks, alcohol, spicy food, and extremes of temperature. Educate on gentle cleansing.
- Systemic therapy. If topicals are insufficient, subantimicrobial doxycycline 40 mg modified-release daily is preferred for long-term anti-inflammatory effect with less antibiotic exposure. If she has already had 3 months of 100 mg daily with partial response, consider extending with the 40 mg MR formulation or switching to a macrolide if tetracyclines are not tolerated.
- Vascular laser. For telangiectasia and persistent erythema, pulsed dye laser (595 nm) or intense pulsed light can be very effective. Counsel on purpura, transient swelling, and the need for multiple sessions.
- Refractory disease. Reassess for Demodex, consider a short course of oral ivermectin or metronidazole, and exclude lupus and other mimics.
Isotretinoin
- Low-dose isotretinoin (e.g., 0.1–0.3 mg/kg/day) is an option for severe or refractory papulopustular rosacea, but it is not first-line and is not indicated for the erythematotelangiectatic subtype.
- Counsel on teratogenicity (pregnancy test, contraception, and pregnancy prevention programme), mucocutaneous dryness, photosensitivity, lipid and liver monitoring, and the risk of an initial flare.
- Explain that her friend's acne is a different disease; isotretinoin can help rosacea but does not address telangiectasia, which requires laser.
- A reasonable approach: optimise topicals and consider laser first; reserve low-dose isotretinoin for persistent papulopustular disease after these measures, with appropriate monitoring.
Follow-up Review at 8–12 weeks to assess response, reinforce trigger avoidance and photoprotection, and reassess the need for laser or systemic therapy.